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E
arly detection of viral infection is a critical step in the initiation of innate and adaptive antiviral responses, ultimately resulting in viral clearance. This detection relies on the selective sensing of viral components such as viral RNA and involves specific innate immune sensors, including Toll-like receptors (TLRs) and retinoic acid gene induced I (RIG-I)-like receptors. Critically, sensing by these receptors must discriminate between self and nonself RNA to protect the host in homeostatic conditions. This is achieved, for example, through the specific detection of 5=-triphosphate residues present on viral RNAs, which facilitate RIG-I activation (1) . In addition, restriction of RNA-detecting TLRs, including TLR3, TLR7, and TLR8 (TLR3/7/8), to the endosomal compartment helps safeguard contact with endogenous RNAs. Nonetheless, such compartmentalization of TLR3/7/8 does not restrict sensing of phagocytosed self-RNAs. Natural modifications of self RNA help to dampen aberrant detection of RNA from phagocytosed cells, as seen with pseudouridine and 2=-O-methyl nucleoside incorporation in rRNA-which represents the bulk of cellular RNA-and the 5= cap of mRNAs inhibiting RNA sensing by TLR7 (2-4) and melanoma differentiation-associated gene 5 (MDA-5) (4) .
RNA editing is a posttranscriptional modification of RNA, converting specific adenosine (A) residues into inosine (I) residues (referred to as A-to-I editing). It is critical to development (5) , and alteration in editing profiles is associated with several pathologies (6) . Recent genome-wide RNA studies indicate that RNA editing is a widespread event, affecting up to 22,000 sites across the human transcriptome (7) . A family of enzymes known as RNA-specific adenosine deaminases (ADARs) carry out A-to-I RNA editing. Owing to their specific interaction with doublestranded RNA (dsRNA) regions, editing of RNA by ADARs is limited to RNA regions with high secondary structure (at least 15 to 20 bp long [8] ), such as Alu-containing sequences (7) .
ADAR-1, one of the two active mammalian deaminases, possesses a type I interferon (IFN)-inducible variant (ADAR-1L or p150), which is induced following detection of viral infection (9) . ADAR-1L is an established component of the antiviral response to certain viral infections, and viral products have evolved to block its activity (9) . By virtue of its ability to associate with adenosine, cytidine, and uridine through non-Watson-Crick wobble base pairing, inosine incorporation into double-stranded regions of viral RNA directly affects the encoded protein sequences (10) . ADAR-1L-deficient mouse embryonic fibroblasts display heightened replication of paramyxoviruses (such as measles virus) and orthomyxoviruses (such as influenza A virus), providing direct evidence of the antiviral activity of RNA editing through ADAR-1L for these viruses (5) . However, there is no clear understanding of how A-to-I editing exerts its antiviral effect on such viruses. Reports suggest that inosine-rich single-stranded RNAs (ssRNAs) can potentiate TLR3 sensing (11, 12) , through the modulation of RNA secondary structures (11) . These findings indicate that in addition to its direct effect on viral coding sequences, Ato-I editing could be used by the cell to facilitate innate immune recognition of foreign RNA.
Endosomal TLR7/8 are specialized in the detection of foreign ssRNAs (13) and are critical to the mounting of an effective innate and adaptive immune response against several viruses (14-16). TLR7 and TLR8 recognize different RNA sequences on the basis of specific motifs (17) . In humans, TLR7 is predominantly expressed in plasmacytoid dendritic cells (pDCs), which is related to its ability to induce high levels of IFN-␣ (13); TLR8, on the other hand, is restricted mostly to monocytes/macrophages, explaining its ability to drive high tumor necrosis factor alpha (TNF-␣) production (13) . Conversely, mouse Tlr7 is expressed in both pDCs and monocytes and is essential to RNA sensing, while mouse Tlr8 is dispensable (13) . As such, it is well accepted that IFN-␣ production is indicative of TLR7 recruitment and that production of TNF-␣ reflects TLR8 engagement following ssRNA transfection in human peripheral blood mononuclear cells (PBMCs) (13) . In mice, however, both TNF-␣ and IFN-␣ production relate to Tlr7 activation (13) . We and others have previously established that TLR7/8 sensing of ssRNAs is strongly dependent on the propensity of ssRNAs to form inter-and intramolecular secondary structures, with the limitation that perfect dsRNA molecules are less stimulatory than imperfect ones (13, 18, 19) . Whether or not inosine incorporation in RNA can modulate TLR7/8 sensing has not been characterized to date.
Here, we investigate the impact of inosine incorporation into ssRNAs on the activation of TLR7/8. We establish that inosine incorporation in ssRNA can increase TLR7/8 sensing, in a sequence-specific manner. Our findings provide evidence that Ato-I editing of structured viral RNAs can act to facilitate their sensing by TLR7/8.
MATERIALS AND METHODS
Cell isolation and culture. Blood was collected from healthy male donors in heparin-treated tubes. PBMCs were purified with Ficoll-Paque plus (GE Healthcare) as previously reported (20) . PBMCs were plated at 200,000 per well of a 96-well plate in 150 l of RPMI 1640 plus L-glutamine medium (Invitrogen Corporation), complemented with 1ϫ antibiotic/antimycotic and 10% fetal bovine serum (FBS) (Invitrogen Corporation), referred to as complete RPMI. The cells were incubated for 4 h at 37°C in 5% CO 2 atmosphere before stimulation by ssRNAs and dsRNAs. Immortalized Tlr7 Ϫ/Ϫ bone marrow macrophages (BMMs) and wildtype (wt) BMMs were generated using the J2 retrovirus encoding v-raf and v-myc as previously described (19) and were maintained in 80% Dulbecco's modified Eagle medium (DMEM) supplemented with 1ϫ antibiotic/ antimycotic and 10% FBS (referred to as complete DMEM), with 20% L-929 cell-conditioned medium. Human acute monocytic leukemia (THP-l) cells were grown in suspension in complete RPMI. Mouse LA-4 lung epithelial cells were grown in F-12K nutrient mixture, Kaighn's modification (Gibco). THP-1, Tlr7 Ϫ/Ϫ , and Tlr7 wt/wt BMMs were passaged 1:3 or 1:5 every 2 or 3 days, respectively. For THP-1 experiments, 80,000 phorbol myristate acetate (PMA)-activated cells were primed for 6 h with 100 U/ml IFN-␥ (10 6 U/ml; Chemicon) before stimulation with ssRNAs, as previously described (21, 22) .
Isolation of BMMs. For stimulation of primary mouse BMMs with ssRNAs, bone marrow extraction and differentiation were carried out following standard procedures (23) . Briefly, femurs from wild-type C57BL/6 mice were flushed with complete DMEM, and cells were plated in complete DMEM supplemented with 20% L-929 cell-conditioned medium in T75-treated flasks for 6 days at 37°C in a 5% CO 2 atmosphere. On day 6, the cells were collected, plated at 80,000 cells per well of a 96-well plate in 150 l DMEM complete, and incubated overnight at 37°C in 5% CO 2 atmosphere prior to stimulation on day 7.
Isolation of murine plasmacytoid dendritic cells. Splenic DCs were isolated from age-matched wild-type and Tlr7-deficient (24) spleens, as previously reported (25) Fig. 2 ) was performed as previously reported (20, 22) . ss/dsRNAs and purified viral RNAs were transfected with dioleoyl trimethylammonium propane (DOTAP; Roche) and pure RPMI in biological triplicate as previously described (19) (20) (21) (22) . The ratios of DOTAP to ssRNA (at 80 M) were 3.74 g/l of ssRNA (see Fig. 1, 2, 3 , and 6D) and 7.78 g/l of ssRNA (see Fig. 6B and C). Following stimulation, the samples were incubated overnight for 16 to 18 h before cytokine measurement by enzyme-linked immunosorbent assay (ELISA). Gardiquimod (chemical TLR7 agonist), Pam3CSK4 (TLR2/1 agonist), CL075 (mouse TLR7 and human TLR8 chemical agonist), and R848 (human TLR7/8 chemical agonist) were used as positive controls. Sequences of nonimmunostimulatory ss41 RNA (ss41-N) and 2=O-methyl (2=Ome) RNA (AMO NC) were previously reported (19, 27) . A DOTAP-only (referred to as "Mock") control was used in all experiments to control for the effect of DOTAP. The control ligands were purchased from Invivogen and were directly added to medium to a final concentration of 1 to 2 g/ml (Gardiquimod, CL075, and R848) or 100 ng/ml (Pam3CSK4). Stimulations were carried out in biological triplicate in all experiments.
Detection of cytokines. Human TNF-␣ and mouse TNF-␣ were measured using BD OptEIA ELISA sets according to the manufacturer's instructions (BD Biosciences). Human and mouse IFN-␣ detection was carried out by sandwich ELISA as previously reported (21, 22, 26) . Tetramethylbenzidine substrate (Sigma-Aldrich) was used for quantification of the cytokines on a Fluostar Optima (BMG Labtech) plate reader.
SYBR green melt curve assay. The SYBR green melt curve assay relies on the ability of SYBR green to fluoresce up to 1,000-fold more intensely when intercalated in the minor groove of two strands of nucleic acids and is adapted from studies of DNA melt curves (28) . Approximately 2 g of ssRNA (4 l of 80 M ssRNA) diluted in 10 l duplex buffer was mixed with 10 l of Power SYBR green PCR Master Mix (Applied Biosystems) and analyzed on a Bio-Rad iQ5 iCycler. Following denaturation of ssRNAs for 4 min at 95°C, the samples were cooled to 20°C using a minimal ramp (to allow formation of secondary structures) and kept for 1 min at 20°C prior to being subjected to the melting curve (from 20°C to 95°C-151 steps of 0.5°C increments, 10 s per step). For each melt curve, relative fluorescence units (RFU) measured were corrected for background RFU at 95°C and reported to the fluorescence measured at 20°C.
Isolation of influenza virus RNA. Type A influenza virus strains A/PR/8/34 (H1N1) (PR8) and A/Brazil/11/78 (H1N1) (BRA) were grown in 10-day-old embryonated hens' eggs using standard procedures (29) . Cells from allantoic fluid were pelleted at 14,000 rpm for 30 min at 4°C, and the RNA was extracted from the cell pellet using the RNeasy Minikit (Qiagen) according to the manufacturer's instructions. RNA concentrations were quantified using a Nanodrop (Thermo Scientific). For RNA from infected cells, a T-75 flask of LA-4 cells was infected with strain PR8 or with a PR8 virus lacking the NS1 gene (referred to as PR8-⌬NS1 or ⌬NS1; a kind gift from A. Garcia-Sastre [30] ) for 24 h (multiplicity of infection of 10). RNA was extracted with the RNeasy Minikit (Qiagen). For calf intestinal phosphatase treatment, 3 g of total RNA was treated with 5 units of Antarctic phosphatase (New England BioLabs) in the presence of 20 units of RNaseOUT (Invitrogen Corporation) for 2.5 h at 37°C. RNA was subsequently column purified using the innuPREP microRNA kit (Analytik Jena). RNA integrity was analyzed using the Agilent 2100 Bioanalyzer with the RNA 6000 Nano kit (Agilent Technologies). For PBMC stimulation experiments, ϳ250 ng of viral RNA (see Fig. 4 ) or 0.8 to 3.2 g of total cellular RNA (see Fig. 5 ) was mixed with 21 l of DOTAP and supplemented with pure RPMI up to 150 l. Following incubation for 5 to 10 min, 50 l of the resultant mix was added to each well, to give a final 200 l per well of a 96-well plate.
RT-qPCR. Viral RNA (50 ng) was reverse transcribed into cDNA using the High-Capacity cDNA archive kit (Applied Biosystems) according to the manufacturer's instructions. Reverse transcription quantitative real-time PCR (RT-qPCR) was carried out with the SYBR GreenER qPCR SuperMix for iCycler instrument (Invitrogen Corporation) on a Bio-Rad iQ5 iCycler. Amplification of viral genomes was carried out using specific primers for a normal and hyperedited 100-bp region of both PR8 and BRA strains (within the HA gene). These regions were inferred from previous reports of influenza virus hyperedited sequences (31) . Amplicons were sequence verified and used to generate standard curves for the quantification of gene expression. Relative editing was calculated by normalizing hyperedited RNA levels to normal RNA levels. The sequences of the primer pairs used are described in Table 1 .
Ion Torrent RNA sequencing using the fusion PCR method. Cyclelimited PCR using specific Ion Torrent compatible primers (see DS primer in Table 1 ) was carried out on the viral cDNA previously used for RT-qPCR, using Platinum PCR SuperMix High Fidelity (Applied Biosystems) according to the manufacturer's instructions. The primers included degenerated bases to allow for equal amplification of edited targets. Hyperedited amplicons were purified by gel migration and Agencourt AMPure XP Reagent (Applied Biosystems), before normalization and pooling (BRA and PR8 samples were pooled). RNA sequencing was carried out using one 318 Ion Torrent chip with 200-bp chemistry according to the manufacturer's protocol. RNA sequencing was carried out in reverse orientation to the genomic viral RNA. We obtained a total of 1,029,246 reads and 1,202,254 reads for the PR8 and BRA samples, respectively.
Bioinformatic analysis of Ion Torrent sequencing. Sequences were aligned to reference viral sequences CY020293.1 and EF467821.1 (GenBank) using Torrent Suite 2.2 software (Life Technologies). Identification of the number of mutations (A-to-G, C-to-U, etc.) for each read was computed using a proprietary Perl script that utilized the Bio::DB::Samperl module (available from http://search.cpan.org/ϳlds/Bio-SamTools/lib/Bio/DB/Sam .pm). Critically, we noticed that inclusion of primer sequences strongly biased the occurrences of A-to-G mutations relative to genomic viral RNA, and we therefore excluded primer regions in our analyses.
Adar-1 RNA interference of LA-4 cells by reverse transfection. A highly potent siRNA targeting the three main three-splice variants of mouse Adar-1 (NM_001038587, NM_001146296, and NM_019655) was selected through high-throughput screening of 24 siRNA duplexes (IDT). Table 1 . Statistical analyses. Statistical analyses were carried out using Prism 5 (GraphPad Software Inc.). Two-tailed unpaired t tests with Welch's correction were used from a minimum of six biological values (from a minimum of two independent experiments). Significance was noted as follows: *, P Յ 0.05; **, P Յ 0.01; ***, P Յ 0.001; ns, nonsignificant.
RESULTS
Inosine incorporation in ssRNA can potentiate RNA sensing by immune cells. We and others have previously reported that although directly dependent on the presence and proportion of uridine residues and associated motifs, TLR7/8 sensing of ssRNAs could be modulated by the propensity of RNAs to form inter-and intramolecular secondary structures (18, 19, 22, 32) . To investigate the potential effect of inosine incorporation into ssRNAs on innate immune sensing, we initially studied the immunostimulatory profiles of a set of 25-nucleotide (nt) synthetic RNAs. These included five inosines dispersed throughout the center of the oligonucleotide (ssIA), a central stretch of four consecutive inosines (ssIB), and a central stretch of four consecutive uridines (ssU) (Fig. 1A) . The human TLR8-specific chemical agonist CL075 (also known as 3M002) was used as a positive control. Human PBMCs stimulated with increasing concentrations of liposome-complexed ssRNAs showed a strong increase in TNF-␣ production with ssIA and ssU, while an increase was seen only at 600 nM with ssIB, compared to the native ssN sequence (Fig. 1B) . However, IFN-␣ levels were not increased with ssIA or ssIB (Fig. 1B) , suggesting that the inosine modification of ssIA primarily affected TLR8 sensing (13) . In addition, the ability of ssIA to induce greater immunostimulation than ssN was also observed in TLR8-responsive human monocytic THP-1 cells (22) (Fig. 1C ) but was absent in mouse BMMs, which lack the Tlr8 response (22) (Fig. 1D) . CL075, which activates Tlr7 in mouse, was used as a positive control. Collectively, these results suggest that selective inosine incorporation into ssRNAs could potentiate sensing by TLR8 in the context of this ssRNA sequence.
The effect of inosine incorporation on TLR7/8 sensing is restricted to immunostimulatory ssRNAs. Our observation that ssIA exerted increased TLR8 recruitment compared to ssIB indicated that the position of inosine residues within the ssRNA sequence was critical in their effect on TLR8 sensing and that potentiation of immune stimulation did not relate to the presence of the inosine residues alone. To confirm this hypothesis, we investigated the impact on cytokine production of five inosines dispersed throughout the center of an oligonucleotide devoid of uridine residues (ss41-L), which does not activate TLR7/8 (19, 33) (Fig.  2A) . ss41-L and its inosine variant, ss41-L-I, failed to significantly induce any TNF-␣ (Fig. 2B) or IFN-␣ (data not shown) production in human PBMCs, even at high dose. On the other hand, mFOLD structural in silico prediction of ssN used in the experiment illustrated in Fig. 1 indicated that this oligonucleotide was prone to a high degree of self secondary structure (Fig. 2C, right) . Inosine and its DNA variant, deoxy-inosine, can form wobble base pairing with adenosine, cytidine, and uridine. We therefore speculated that some of the effects of inosine incorporation in ssIA and ssIB could be due to modifications of secondary structures. To assess this hypothesis, we next studied TLR7/8 recruitment by ssN, ssIA, ssIB, and ssU duplexed to the complementary sequence of ssN (resulting in dsN, dsIA, dsIB, and dsU) (Fig. 2C, left) . Experiments in human PBMCs showed no increase in TNF-␣ or IFN-␣ production with either dsIA or dsIB compared to ssN (Fig. 2D) , directly implicating formation of secondary structures in the effect of inosine incorporation in ssIA and ssIB. To determine whether structural variations, independent of inosine residues, were responsible for increased immune stimulation, we studied the immunostimulatory activity of a variant of ssIA synthesized with DNA deoxy-inosine residues substituted for inosine residues (ssdIA). Unlike ssIA, ssdIA failed to increase TNF-␣/IFN-␣ pro- duction in human PBMCs (Fig. 2E) , underlining the critical role for ribo-inosine moieties in the effect of ssIA. Collectively, these results suggested that unlike uridine residues, ribo-inosine residues did not directly activate TLR7/8 but rather potentiated sensing of uridine motifs through modulation of inter-and intramolecular secondary structures. Inosine-mediated structural modification of ssRNA modulates TLR7 sensing. In order to further ascertain the ability of inosine incorporation to modulate TLR7/8 sensing through the modulation of ssRNA structure, we investigated the effect of a single inosine mutation on the secondary structure and immune activity of a previously characterized immunostimulatory ssRNA (19) . Relying on the correlation between mFOLD-predicted (34) secondary structures of ssRNAs and the fluorescence of ssRNAs with the nucleic acid intercalant SYBR green (data not shown), we first demonstrated that inosine incorporation into B-406-AS (giving B-406-AS-i), resulting in the formation of an I·C base pair, robustly increased the strength of the intramolecular secondary structure of this ssRNA, as revealed by the higher energy (temperature) required to decrease SYBR green fluorescence by 80% (Fig.  3A and B, compare B-406-AS and B-406-AS-i). Importantly, the wobble I·C pair in B-406-AS-i was less potent than the G·C pair in B-406-AS-1 in its ability to modulate intramolecular secondary structure, as revealed by the SYBR green melt curve assay ( Fig. 3A and B, compare B-406-AS-i and B-406-AS-1). In agreement with a role for secondary structure in the modulation of TLR7/8 signaling (19) , the I·C base pair of B-406-AS-i robustly increased the immunostimulatory activity of this ssRNA in human PBMCs compared to the native B-406-AS sequence, but not as potently as the G·C pair of B-406-AS-1, which conferred greater secondary structure (Fig. 3C , compare B-406-AS, B-406-AS-i and B-406-AS-1). Importantly, in the context of the B-406-AS ssRNA, inosine modification potentiated IFN-␣ rather than TNF-␣ production, suggesting a preferential effect of inosine on TLR7 (22) . To determine the direct involvement of TLR7 in the effect of B-406-AS-i, we assessed the ability of B-406-AS-i to induce immune stimulation when cotransfected with an RNA containing 2=O-methyl (2=Ome) groups, given that 2=Ome-modified RNAs act as TLR7 antagonists (Fig. 3D) (3) . 2=Ome RNA cotransfection entirely ablated B-406-AS-i-induced IFN-␣ production, consistent with the requirement of TLR7 in the sensing of the inosine modification. Nonetheless, 2=Ome RNA cotransfection did not ablate TNF-␣ production by B-406-AS-i, suggesting residual TLR8 sensing, nor did it prevent IFN-␣ production by the TLR9 ligand CpG DNA (Fig. 3D) . Similarly, the requirement for TLR7 in the sensing of B-406-AS-i was confirmed using pDCs from Tlr7 Ϫ/Ϫ mice, which lacked IFN-␣ production in response to B-406-AS-i but not the Tlr9 agonist (Fig. 3E) . Taken together, these results demonstrate that selective inosine incorporation into ssRNA can potentiate TLR7 RNA sensing, through its impact on inter-and intramolecular secondary structures.
Increased inosine content in viral RNA correlates with increased TNF-␣ production in human PBMCs. The data thus far suggested that inosine incorporation into structured short immunostimulatory ssRNA had the potential of increasing TLR7/8 sensing, depending on the sequence modified or the localization of inosine modification(s). To determine the biological significance of these results, we next investigated the impact of inosine incorporation into influenza virus A (ssRNA virus) RNA on its immunostimulatory activity. Relying on RT-qPCR amplification (Fig. 4A and B) . Noteworthy, this RNA contained only a small proportion of cellular RNA (revealed by 18S and 28S ribosomal RNAs; data not shown), suggesting enrichment of viral RNA. For this reason, this RNA is referred to as "viral RNA" in the rest of this discussion. We next assessed the ability of this viral RNA with various levels of editing to activate TLR7/8 in human PBMCs; the chemical agonists Gardiquimod and CL075, specific to human TLR7 and 8, respectively, were used as positive controls. Stimulation of human PBMCs with liposome-complexed viral RNA revealed a correlation between the content of hyperedited RNAs and the ability of the viral RNA to induce TNF-␣, in that RNA samples from both viruses with more hyperedited RNAs displayed greater ability to induce TNF-␣ production [ Fig. 4A and B, compare PR8 (1) to PR8 (2) and BRA (1) to BRA (2)]. However, there was no significant effect on IFN-␣ production, indicating a preferential role of hyperedited content on TLR8 activity ( Fig. 4A and B) . A recent report suggested that up to 1% of the influenza A viral RNA produced by infected chicken fibroblasts in vitro was affected by A-to-I editing (31) . To assess further the inosine content of the viral RNA samples studied above, analyses with Ion Torrent targeted RNA sequencing were carried out. Inosine (I) is changed to guanosine (G) during reverse transcription, allowing for the identification of A-to-I editing sites (as A-to-G mutations on the viral genomic strand or U-to-C mutations on the antigenomic strand). In agreement with Suspene et al., this analysis revealed the predominant A-to-G/U-to-C mutation of viral RNA across all other mutations, with sequencing reads with at least two A-to-G/U-to-C mutations representing up to 0.8% of all reads for PR8 (Fig. 4C) . The antigenomic RNA (replication template) was also edited (as shown by U-to-C mutations), confirming previous observations (31) . Noteworthy, C-to-U mutations were over three times more abundant than the other mutations for BRA, indicating possible enriched C-to-U editing (data not shown). Specific analysis of A-to-G frequency of mutations revealed that while ϳ0.4% of all reads contained two or more A-to-G mutations, the proportion of reads with three or more A-to-G mutations was ϳ10-fold lower (ϳ0.04 to 0.06%) (Fig. 4D) . Nonetheless, a third of the reads with at least three mutations had six mutations, suggesting that these transcripts were hyperedited (Fig. 4D) . Collectively, these results suggest a direct impact of inosine incorporation on the immunostimulatory activity of influenza A viral RNA.
RNA from influenza-infected cells activates TLR7/8, independent of 5=-triphosphate. Mammalian cellular RNAs such as ribosomal RNAs contain various modifications such as pseudouridine and 2=-O-methyl nucleoside incorporation, which avoid mice and Tlr7 Ϫ/Ϫ mice were stimulated with 100 nM DOTAP-complexed B-406-AS-i ssRNA or 5 M CpG DNA and incubated overnight. Mouse IFN-␣ production was measured by specific ELISA in technical triplicate. The data are averaged from two independent experiments. SEM is shown in panels B to E. aberrant activation of innate immune sensors from self-RNA (2). In line with this concept and the direct inhibitory effect of 2=-Omethyl moieties in Tlr7 sensing (3), total RNA from epithelial cells transfected in human PBMCs did not induce production of IFN-␣ or TNF-␣ (Fig. 5A , condition "Cells only"). Conversely, total RNA from influenza virus PR8-infected epithelial cells, although containing more than 60% of 18S and 28S rRNA (data not shown), induced a strong IFN-␣ production concurrently with a mild TNF-␣ secretion in human PBMCs (Fig. 5A, PR8 and PR8-⌬NS1 conditions). Calf intestinal phosphatase (CIP) treatment of the RNA from PR8-infected cells resulted in a strong reduction in IFN-␣ production (compare IFN-␣ levels in Fig. 5A and B) , indicating the involvement of 5=-triphosphate moieties in IFN-␣ production (1). Nonetheless, RNA from cells infected with a mutant PR8 virus lacking the NS1 protein (which is thought to impair ADAR-1 editing activity [31] ) (⌬NS1) retained the ability to induce TNF-␣ production following CIP treatment, suggestive of TLR8 recruitment rather than RIG-I activation (35) . The RNA from PR8-⌬NS1-infected cells contained a higher proportion of hyperedited PR8 transcripts than RNA from wild-type PR8-infected cells (Fig. 5C) , suggesting a putative involvement of RNA editing in this effect. In addition, CIP-treated RNA from PR8-⌬NS1-infected cells retained the ability to activate TNF-␣ production in immortalized BMMs from Tlr7 wt but not from Tlr7 Ϫ/Ϫ mice (Fig. 5D , compare "PR8-⌬NS1 ϩ CIP" conditions in Tlr7 wt and Tlr7 Ϫ/Ϫ cells); on the other hand, non-CIP-treated RNA was able to induce TNF-␣ production independently of the presence of Tlr7, which is indicative of RIG-I recruitment. The Tlr2/1 ligand, Pam3CSK4, confirmed that both Tlr7 wt and Tlr7 Ϫ/Ϫ cells were able to produce TNF-␣. To directly involve Adar-1 editing in the TNF-␣ production seen in RNA from PR8-⌬NS1-infected cells, we decreased Adar-1 expression through RNA interference in LA-4 cells prior to the infection with PR8-⌬NS1 (Fig. 5E , compare siADAR and the control siNC5 conditions). In accord with the results above, CIP treatment of the RNA from PR8-⌬NS1-infected cells showed a significant decrease in IFN-␣ production in human PBMCs, regardless of Adar-1 expression (Fig. 5F ). TNF-␣ levels, however, were significantly decreased following downregulation of Adar-1 (siADAR condition), but not with the nontargeting control siNC5. This directly implicates Adar-1 in the ability of CIP-treated RNA to induce TNF-␣. Collectively, these results suggest that a small proportion of Adar-1-edited viral RNA is able to potentiate sensing of cellular RNA, independently of 5=-triphosphate/RIG-I recruitment, in a human TLR8-and mouse Tlr7-dependent manner. A-to-I editing in a proportion of viral RNA potentiates TLR7 sensing. Having shown that (i) purified viral RNA with greater inosine content (Fig. 4) and (ii) RNA from infected cells with greater viral hyperediting (Fig. 5) were more immunostimulatory, we next sought to validate the direct contribution of A-to-I editing on synthetic RNAs encompassing a 90-nt hyperedited portion of PR8 RNA previously analyzed by sequencing (Fig. 6A ) (reference 31 and data not shown). We wished to exclude possible self RNA cleavage products that could have contaminated our viral RNA preparations (36) . Unexpectedly, comparison of the immunostimulatory profiles of each individual 30-nt segment with (S1i, S2i, and S3i) or without (S1, S2, and S3) inosine editing showed no increase in cytokine production with inosine editing for any of the fragments (Fig. 6B) . Noteworthy, there appeared to be a degree of correlation between the frequency of TLR8-specific AU motifs (Fig. 6A, shaded in gray) (17) that were converted to IU motifs and the negative impact of A-to-I editing on TNF-␣ production. As such, S2i, which lost three AU motifs, displayed a near-significant (P ϭ 0.0512) decrease in the induction of TNF-␣ compared to S2 (Fig. 6B) . Nonetheless, we speculated that formation of complex intermolecular secondary structures could be at play in the effect of inosine on TLR7/8 sensing of viral RNA seen in Fig. 4 and 5, and therefore we studied pools of 30-nt ssRNAs with or without inosine editing (Fig. 6C) . While no increase in cytokine production was seen using pure pools of inosine-modified RNA (condition "ipool"), the addition of a small quantity of inosine-modified RNAs (12.5%) to the pool of native RNAs resulted in an ϳ2-fold increase in TNF-␣ production and a small increase in IFN-␣ levels in human PBMCs (Fig. 6C , compare "ipool 12.5%" with "wtpool" conditions). Significant potentiation of cytokine production with as low as 1% of edited transcripts was confirmed in immortalized BMMs from Tlr7 wt mice, but not from Tlr7 Ϫ/Ϫ mice, for TNF-␣ of PR8 influenza virus (PR8-⌬NS1, shown as "⌬NS1," lacks the NS1 gene, which interacts with Adar-1 and decreases A-to-I editing [31] ) was transfected in human PBMCs (1.3 g/ml), and cytokine production was measured after overnight incubation. The "Cells only" condition refers to RNA from noninfected LA-4 cells. (B) The same RNA as described for panel A was treated with CIP (ϩCIP) (see Materials and Methods), prior to transfection into human PBMCs (1.6 g/ml) and analysis of cytokine production after overnight incubation. Data shown in panels A and B are averaged from a minimum of two independent experiments in biological triplicate. Unpaired two-tailed t tests comparing PR8 and PR8-⌬NS1 conditions are shown in panel B. (C) The same RNA from infected cells as described for panel A was reverse transcribed and analyzed by qPCR for levels of hyperedited PR8 RNA relative to the levels of mouse Gapdh mRNA. RT-qPCR data shown are averaged from two independent experiments. (D) Total RNA from PR8-⌬NS1-infected LA-4 cells with (ϩCIP) or without CIP was transfected in Tlr7 wt/wt and Tlr7 Ϫ/Ϫ mouse BMMs (2.6 g/ml). Cytokine production was measured by specific ELISA following overnight incubation. Results shown are averaged from a minimum of two independent experiments in biological triplicate. Unpaired two-tailed t tests using "Cells only" as a reference are shown. (E) Total RNA from PR8-⌬NS1-infected LA-4 cells previously transfected with siADAR or the nontargeting control siNC5 was analyzed by RT-qPCR for Adar-1 mRNA levels (see Materials and Methods). The data shown are averaged from technical triplicates, relative to the levels of mouse Gapdh mRNA. (F) The RNA described in panel E was treated with CIP (ϩCIP) or left untreated, prior to transfection into human PBMCs (1.6 g/ml for nontreated RNA, 3.2 g/ml for CIP-treated RNA) and analysis of cytokine production after overnight incubation. The data are averaged from two blood donors in biological triplicate. Unpaired two-tailed t tests are shown. SEM is shown in panels A, B, D, E, and F.
( Fig. 6D ) and interleukin-6 (IL-6) production (data not shown). These results establish that small proportions of A-to-I hyperedited RNAs can facilitate sensing of viral RNA by Tlr7.
DISCUSSION
ADAR-1L-mediated A-to-I editing is a critical component of the antiviral response against several viruses, including measles and influenza A viruses (5) . A recent report analyzing the A-to-I editing content of influenza A viral RNA from infected chicken fibroblasts suggested that A-to-I editing is frequent during viral replication, potentially modifying up to 1% of viral RNA (31) . In our analyses of two strains of influenza A virus, we show that as much as 0.8% of viral RNA can be edited following standard propagation of virus in hens' eggs (as carried out for the production of influenza vaccine). In accord with the work of Suspene et al., this suggests that A-to-I editing is indeed a frequent event during viral replication (31) . We also confirm that both genomic and the replication template of influenza A virus can be edited (31) . We found that an important proportion of RNAs with at least three A-to-G mutations had in fact at least six A-to-G mutations, indicative of their hyperediting. However, our observations suggest that hyperedited viral RNAs represent only a fraction of all A-to-I edited RNAs. While such mutations would directly impact the affected clones and their ability to produce effective viruses, it is however most likely that such direct effects on Ͻ1% of the clones do not account for much of the overall antiviral properties of ADAR-1L-mediated A-to-I editing. Rather, inosine incorporation in structured viral RNAs could facilitate recognition of nonself RNA (11, 14, 31) . Under this rationale, a small proportion of edited viral RNA could elicit a strong antiviral effect through the downstream induction/amplification of type I IFN signaling. This is supported by two independent reports directly implicating a role for inosine residues in the activation of TLR3 (11, 12) .
In the current study, we set out to investigate the impact of inosine incorporation into ssRNAs on TLR7/8 sensing. We provide several lines of evidence supporting the direct effect of inosine incorporation into ssRNA on the potentiation of TLR7/8 sensing. First, we observed that inosine addition to short synthetic immu- The indicated ssRNAs were transfected with DOTAP to a final 100 nM in human PBMCs and incubated overnight. Cytokine production was measured by specific ELISA. Data shown are averaged from three independent experiments in three blood donors, in biological triplicate. Unpaired t test is shown. (C, D) Indicated pools of pure ssRNAs ("wtpool" consists of S1, S2, and S3, while "ipool" consists of S1i, S2i, and S3i, in a 1:1:1 ratio) or a mixture of both pools (12.5% and 1% ipool conditions) were transfected with DOTAP to a final concentration of 100 nM in human PBMCs (C) or 200 nM in Tlr7 wt/wt and Tlr7 Ϫ/Ϫ mouse BMMs (D). Cytokine production was measured by specific ELISA following overnight incubation. Results shown are representative of two independent experiments in biological triplicate in two blood donors (C) and averaged from three independent experiments in biological triplicate (D). (D) Unpaired two-tailed t tests using "wtpool" as a reference are shown. SEM is shown in panels B, C, and D.
nostimulatory ssRNA molecules could result in increased production of IFN-␣ or TNF-␣ by human PBMCs, in a sequence-specific manner (Fig. 1, 2, and 3) . Given that TLR7 and TLR8 recognize different RNA motifs (17) , the sequence-specific potentiation of IFN-␣ or TNF-␣ by inosines is indicative of the specific recruitment of TLR7/8. Critically, ablation of IFN-␣ production of B-406-AS-i with a TLR7 antagonist in human PBMCs, together with the lack of an effect of B-406-AS-i in mouse Tlr7 Ϫ/Ϫ pDCs, directly implicates TLR7 in the detection of inosine-modified ssRNA (Fig. 3) . In addition, the finding that the inosine-rich ssIA promoted specific induction of TNF-␣ in both human PBMCs and PMA-activated THP-1 monocytic cells but not in primary mouse BMMs supports the notion that RNA sensing by human TLR8 can also be facilitated by inosine incorporation (Fig. 1) . This is in accord with the observation that the double-stranded form of ssIA, dsIA, did not elicit an increase in TNF-␣ production, given that TLR8 sensing is strongly repressed by annealing of complementary oligonucleotides (18) .
Second, we demonstrate that a nonimmunostimulatory inosine-rich ssRNA, ss41-L-I (lacking uridine residues), cannot elicit an immune response following DOTAP-mediated delivery in human PBMCs. We and others have previously demonstrated that TLR7/8 sensing is strongly reliant on the presence of uridine residues (19, 37) , further implicating TLR7/8 in the detection of inosine-modified immunostimulatory RNAs (Fig. 2) . Third, it has previously been speculated that TLR7/8 sensing of ssRNAs relates to their tendency to form inter-and intramolecular uridine-rich secondary structures (37) . In agreement with this, we have previously observed that the position of uridine modifications within the secondary structure of an ssRNA has an important effect on immunostimulation (22) . Given the ability of inosine to form wobble base pairing with adenosine, cytidine, and uridine, inosine incorporation is expected to directly impact on the ability of an ssRNA to form secondary structures. In accord with a role for inosine in the modulation of TLR7/8 sensing through structural variations, we demonstrate here that the position of inosine incorporation is critical to the effect on TLR7/8 sensing (Fig. 1) . In addition, we establish a direct correlation between the inosinemediated modulation of inter-and intramolecular ssRNA structures and activation of TLR7 with B-406-AS-i (Fig. 3) . Nonetheless, the effect of inosine on immune stimulation is not limited to its structural activity and was not reproduced by its DNA analog deoxy-inosine (ssdIA), while also favoring structural variations (Fig. 2) . This inhibition of immunostimulatory activity by the DNA analog of inosine is similar to that seen with deoxy-uridine residues, which repress sensing of ssRNAs when replacing uridine residues (37) . TLR7/8 can be activated by ssRNA and dsRNA, although the immunostimulatory role of dsRNA is greater when the affinity for the dsRNA duplex is weaker, particularly for TLR8 (18, 19) . In the context of viral infection, we therefore hypothesized that ADAR-1L-mediated A-to-I editing of structured RNAs could facilitate TLR7/8 sensing by destabilizing dsRNA structures. However, immunostimulatory analyses of individual ssRNAs mimicking a known structured hyperedited region of influenza A virus indicated that A-to-I editing did not enhance TLR7/8 sensing when present in 100% of the molecules (Fig. 6) . In fact, an ϳ50% decrease in human TNF-␣ was even visible with one of the sequences (S2i) and when the sequences were pooled, indicating an inhibitory effect of A-to-I editing on TLR8 sensing. While counterintuitive in light of our other results with ssRNAs where inosine incorporation was not restricted to adenosine residues (Fig. 1, 2, and 3) , we propose that this relates to the loss of TLR8-specific AU-rich motifs (changed to IU motifs) (17) . In line with this concept, S2i ssRNA lost three AU motifs following A-to-I editing and displayed a marked decrease in TNF-␣, while IFN-␣ levels were unaffected when transfected in human PBMCs. Further involving TLR8 in this event, pools of inosine-modified ssRNAs did not promote such a decrease in TNF-␣ production in mouse macrophages, in which Tlr8 does not contribute to ssRNA sensing (13) . It is also possible that changes in secondary structure less favorable to the detection of these ssRNAs are also at play.
Nonetheless, under the rationale that A-to-I editing affected only small proportions of viral RNAs, we postulated that the observed structural effects of inosine on ssIA and B-406-AS-i ssRNA could increase the formation of complex intermolecular structures in A-to-I edited RNA, even if present in a small proportion of sequences. Accordingly, we demonstrate here that physiological levels (between 1 and 12.5%) of inosine-modified ssRNA molecules can potentiate RNA sensing and result in increased TNF-␣ production by human and mouse macrophages. We propose that this potentiation is mostly TLR8 dependent in human PBMCs, as revealed by the preferential increase in TNF-␣ production. As such, A-to-I editing exhibits a dual activity, which can both potentiate and antagonize TLR8 sensing, the latter diminishing with a biologically relevant low concentration of inosine-modified RNAs. Noteworthy, we have previously shown that human TLR7 was necessary for ssRNA sensing in human monocytic cells (22) , and it is thus most likely that TLR7 is also at play in the macrophage sensing of inosine-modified RNA. We directly establish a role for mouse Tlr7 in the effect of inosine-modified ssRNA molecules, through the use of Tlr7 Ϫ/Ϫ macrophages (Fig. 6 ). This role for Tlr7 in the increased detection of A-to-I edited viral RNA is consistent with recent reports demonstrating a critical role for mouse Tlr7 in the immune response to lymphocytic choriomeningitis virus (LCMV) (15, 16) , which is subject to ADAR-1L hyperediting during replication (10) .
Finally, in support of a direct role for A-to-I editing in the sensing of viral RNA by TLR7/8, we show a correlation between the proportion of hyperedited influenza virus RNA and the immunostimulatory activity of this viral RNA in human PBMCs. As with our observations on pools of inosine-modified RNAs, TNF-␣ was predominantly affected by the overall proportion of hyperedited RNA, suggesting preferential modulation of TLR8 activity.
Critically, we also demonstrate that phagocytosis of total RNA from influenza virus-infected cells resulted in TNF-␣ production by human and mouse macrophages, independently of 5=-triphosphate residues and in an Adar-1-dependent manner. Although the direct antiviral activity of 5=-triphosphate-dependent IFN-␣ production was clearly predominant in these experiments, these results confirm a contributing role for human TLR8 and mouse Tlr7 to the sensing of RNA from infected epithelial cells. Because modified cellular RNA is essentially nonimmunostimulatory, it remains to be determined whether inosine residues directly compete with inhibitory moieties such as 2=-O-methyl bases, to result in TLR7/8 sensing. Altogether, our results support a role for TLR7/8 in the production of TNF-␣ by macrophages in response to phagocytosed infected epithelial cells. In addition to its direct proinflammatory activity, TNF-␣ was previously shown to enhance influenza A virus-induced chemokine expression by epithelial cells (38) . This suggests a possible feedback loop between epithelial cells and macrophages, increasing immune cell recruitment to the infected locus.
Collectively, our data establish a novel role for TLR7/8 in the detection of A-to-I edited viral RNA. We propose that Adar-1-mediated inosine incorporation into viral RNA acts to facilitate recognition of nonself RNA by TLR7/8, allowing infected cells to be identified when cleared by phagocytes, such as macrophages. It is unlikely that inosine-modified viral RNA contributes directly to the antiviral response against infected epithelial cells, as they lack TLR7/8 (13) . We speculate that A-to-I editing of structured viral RNA helps to counterbalance the repressive effect of self-RNA from phagocytosed infected cells, thus helping to distinguish between self and nonself RNA, together with other modifications such as 5=-triphosphate (1). Along with reports on TLR3 sensing (11, 12) , the implications of our work may be far-reaching, as our results suggest a novel paradigm whereby A-to-I editing of viral RNA acts to facilitate detection of nonself RNA.
